3D bioprinting is an innovative technology that promises to revolutionize cancer research and treatment by providing more accurate and complex models of tumor tissue. This advancement is particularly significant in the study of cancers involving the BRCA1 gene. Tumor modeling with 3D bioprinting
Researchers from the Stevens Institute of Technology have developed an advanced software tool named "clipping spline," which offers unprecedented capabilities for viewing and analyzing complex 3D biomedical images. This innovation enables deep and comprehensive visualization of optical coherence
Precision medicine represents an innovative approach to disease treatment and prevention that is biomarker-guided and individualized. It incorporates an individual's genetic information along with other social health determinants such as environment and lifestyle. This approach enables healthcare
In a breakthrough development for cancer treatment and deep tissue imaging, researchers at Tokyo Metropolitan University have created a revolutionary dye. This innovative dye is derived from the bile pigment bilatriene and incorporates a unique ring structure designed to bind rhodium and indium
The quest for improved treatment options for metastatic colorectal cancer (mCRC) patients with the BRAF V600E mutation has always been fraught with challenges. Given the aggressive nature of these tumors and the historically poor prognosis associated with this genetic mutation, researchers have
Recent research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has shed light on the survival benefits of anatomic lung resections, specifically lobectomy and segmentectomy, for patients diagnosed with stage 1A non-small cell lung cancer (NSCLC). Utilizing data from the STS
